Nakao, Sanshiro Tsukamoto, Shokichi Takeda, Yusuke Ohwada, Chikako Ri, Chihiro Izumi, Shintaro Kamata, Yuri Matsui, Shinichiro Shibamiya, Asuka Ishii, Arata
...
Published in
International journal of hematology
Criteria for airflow obstruction (AFO) at one year after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in pulmonary function tests (PFTs) are more stringent than the bronchiolitis obliterans syndrome (BOS) criteria of the National Institutes of Health. This single-center, retrospective cohort study evaluated the clinical impact of ...
Murao, Masanobu Kondo, Tadakazu Hamada, Ryota Miyasaka, Junsuke Matsushita, Michiko Otagaki, Ayumi Kajimoto, Taishi Arai, Yasuyuki Kanda, Junya Nankaku, Manabu
...
Published in
Disability and rehabilitation
Advancements in allogeneic hematopoietic stem cell transplantation have improved the survival rates of individuals with malignant hematological disorders, and efforts should now be focused on enhancing their physical function and quality of life.There is a problem that the physical performance of the patients is reduced by the side effects of treat...
Miyazaki, Takuya Tachibana, Takayoshi Suzuki, Taisei Izumi, Akihiko Fujimaki, Katsumichi Sato, Shuku Tamai, Yotaro Michishita, Yusuke Suzuki, Takahiro Ishii, Ryuji
...
Published in
Transplantation and cellular therapy
There are no clear criteria for selecting elderly patients with hematologic malignancies eligible for allogeneic hematopoietic stem cell transplantation (HSCT). This study aimed to evaluate inflammatory and nutritional status biomarkers as prognostic indicators of allogeneic HSCT in elderly patients. We compared the prognostic effects of 4 represen...
Lucero, Josephine Alhumaid, Muhned Novitzky-Basso, Igor Capo-Chichi, Jose-Mario Stockley, Tracy Gupta, Vikas Bankar, Aniket Chan, Steven Schuh, Andre C Minden, Mark
...
Published in
Annals of hematology
Measurable residual disease (MRD) monitoring independently predicts long-term outcomes in patients with acute myeloid leukemia (AML). Of the various modalities available, multiparameter flow cytometry-based MRD analysis is widely used and relevant for patients without molecular targets. In the transplant (HCT) setting, the presence of MRD pre-HCT i...
Robles-Nasta, Max Sánchez-Bonilla, Daniela Gallardo-Pérez, Moisés M. Hernández-Flores, Edgar J. Montes-Robles, Merittzel A. Pastelín-Martínez, María de L. Olivares-Gazca, Juan C. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles, Guillermo J.
ABSTRACT Background: Chronic myelogenous leukemia is a neoplastic proliferation of the granulocytic series. In Mexico, chronic myelogenous leukemia accounts for approximately 10% of all leukemias. Tyrosine-kinase inhibitors are considered front-line therapy in high-income countries, whereas allogeneic hematopoietic stem cell transplantation is a re...
McGuirk, Matthew Shahzad, Moazzam Amin, Muhammad Kashif Khan, Muhammad Atif Bellman, Polina Mudaranthakam, Dinesh Pal DeJarnette, Shaun Lutfi, Forat Ahmed, Nausheen Bansal, Rajat
...
Published in
Transplant immunology
We aimed to investigate factors associated with cytomegalovirus (CMV) viremia and CMV disease and its impact on post-transplant outcomes including overall survival (OS) following allogeneic hematopoietic stem cell transplantation (Allo-SCT). We conducted a single-center retrospective study including 452 Allo-SCT recipients (matched unrelated donor,...
Chen, Ting Li, JiaLi Wei, Xiao Yao, Han Zhu, LiDan Liu, Jia Liu, YuQing Wang, Ping Feng, YiMei Gao, ShiChun
...
Published in
Acta Haematologica
Introduction: Steroid-refractory cGVHD (SR-cGVHD) presents new great challenges for treatment. We have reported that imatinib monotherapy was effective to SR-cGVHD, but the CR rate was not satisfactory and the benefit was not showed specific to some target organs, previously. Imatinib and statin drugs have been recognized to regulate T-cell functio...
Hu, Guan-hua Zhang, Xiao-hui Liu, Kai-yan Xu, Lan-ping Wang, Yu Cheng, Yi-fei Huang, Xiao-jun
Published in
Acta Haematologica
Introduction: The role of haploidentical allogeneic hematopoietic stem cell transplantation (haplo-HSCT) in pediatric patients with relapsed or refractory (R/R) ETV6/RUNX1-positive acute lymphoblastic leukemia (ALL) is unclear. This study aimed to identify prognostic factors and explore the role of haplo-HSCT in the treatment of ETV6/RUNX1-positive...
Sarradon-Eck, Aline Franchina, Loreley Arnault, Yolande Le Corroller, Anne‐gaëlle Zunic, Patricia Marino, Patricia
Abstract Objective Reasons for patients' acceptance of the allogeneic hematopoietic stem cell transplantation (allo‐HSCT) proposed and how their decision may be affected by the long distances involved have not been sufficiently investigated so far. We therefore conducted a qualitative study to identify the factors involved in overseas patients' dec...
Nukui, Jun Tachibana, Takayoshi Miyazaki, Takuya Tanaka, Masatsugu Matsumoto, Kenji Ishii, Yoshimi Numata, Ayumi Nakajima, Yuki Matsumura, Ayako Suzuki, Taisei
...
Published in
International journal of hematology
The clinical implications of recipient bone marrow nucleated cell count (NCC) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain unknown. We conducted a multicenter retrospective study to evaluate the clinical significance of bone marrow NCC prior to allo-HSCT in patients with acute lymphoblastic leukemia. Patients who w...
